BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15546177)

  • 21. [Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery].
    Wang Y; Liang Z; Yuan YH; Han Y; Liu YX; Liu N; Chen YT; Ritter G; Old LJ; Zhang LJ
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):464-8. PubMed ID: 15061963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the cancer/testis antigens AKAP3 and CTp11 by SEREX in hepatocellular carcinoma.
    Song MH; Choi KU; Shin DH; Lee CH; Lee SY
    Oncol Rep; 2012 Nov; 28(5):1792-8. PubMed ID: 22941507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral immune responses to testis antigens in sera from patients with prostate cancer.
    Hoeppner LH; Dubovsky JA; Dunphy EJ; McNeel DG
    Cancer Immun; 2006 Jan; 6():1. PubMed ID: 16401063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning.
    Vaughan HA; St Clair F; Scanlan MJ; Chen YT; Maraskovsky E; Sizeland A; Old LJ; Cebon J
    Cancer Immun; 2004 Jul; 4():5. PubMed ID: 15255672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor effect of antibody against a SEREX-defined antigen (UOEH-LC-1) on lung cancer xenotransplanted into severe combined immunodeficiency mice.
    Mizukami M; Hanagiri T; Yasuda M; Kuroda K; Shigematsu Y; Baba T; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; So T; Takenoyama M; Sugio K; Yasumoto K
    Cancer Res; 2007 Sep; 67(17):8351-7. PubMed ID: 17804751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
    Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
    Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.
    Scanlan MJ; Welt S; Gordon CM; Chen YT; Gure AO; Stockert E; Jungbluth AA; Ritter G; Jäger D; Jäger E; Knuth A; Old LJ
    Cancer Res; 2002 Jul; 62(14):4041-7. PubMed ID: 12124339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients.
    Mischo A; Wadle A; Wätzig K; Jäger D; Stockert E; Santiago D; Ritter G; Regitz E; Jäger E; Knuth A; Old L; Pfreundschuh M; Renner C
    Cancer Immun; 2003 Jun; 3():5. PubMed ID: 12828452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays.
    Gnjatic S; Wheeler C; Ebner M; Ritter E; Murray A; Altorki NK; Ferrara CA; Hepburne-Scott H; Joyce S; Koopman J; McAndrew MB; Workman N; Ritter G; Fallon R; Old LJ
    J Immunol Methods; 2009 Feb; 341(1-2):50-8. PubMed ID: 19041653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer.
    Wang Y; Wu XJ; Zhao AL; Yuan YH; Chen YT; Jungbluth AA; Gnjatic S; Santiago D; Ritter G; Chen WF; Old LJ; Ji JF
    Cancer Immun; 2004 Nov; 4():11. PubMed ID: 15516106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel prostate cancer-associated tumor antigen.
    Miles AK; Rogers A; Li G; Seth R; Powe D; McArdle SE; McCulloch TA; Bishop MC; Rees RC
    Prostate; 2007 Feb; 67(3):274-87. PubMed ID: 17192878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel cancer testis antigen that is frequently expressed in pancreatic, lung, and endometrial cancers.
    Okada T; Akada M; Fujita T; Iwata T; Goto Y; Kido K; Okada T; Matsuzaki Y; Kobayashi K; Matsuno S; Sunamura M; Kawakami Y
    Clin Cancer Res; 2006 Jan; 12(1):191-7. PubMed ID: 16397042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis.
    Yokoe T; Tanaka F; Mimori K; Inoue H; Ohmachi T; Kusunoki M; Mori M
    Cancer Res; 2008 Feb; 68(4):1074-82. PubMed ID: 18281482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NY-ESO-1 may be a potential target for lung cancer immunotherapy.
    Lee L; Wang RF; Wang X; Mixon A; Johnson BE; Rosenberg SA; Schrump DS
    Cancer J Sci Am; 1999; 5(1):20-5. PubMed ID: 10188057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.
    Valmori D; Dutoit V; Liénard D; Rimoldi D; Pittet MJ; Champagne P; Ellefsen K; Sahin U; Speiser D; Lejeune F; Cerottini JC; Romero P
    Cancer Res; 2000 Aug; 60(16):4499-506. PubMed ID: 10969798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning.
    Jäger D; Taverna C; Zippelius A; Knuth A
    Cancer Immunol Immunother; 2004 Mar; 53(3):144-7. PubMed ID: 14727084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
    Odunsi K; Jungbluth AA; Stockert E; Qian F; Gnjatic S; Tammela J; Intengan M; Beck A; Keitz B; Santiago D; Williamson B; Scanlan MJ; Ritter G; Chen YT; Driscoll D; Sood A; Lele S; Old LJ
    Cancer Res; 2003 Sep; 63(18):6076-83. PubMed ID: 14522938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological identification of antigens associated with renal cell carcinoma.
    Koroleva EP; Lagarkova MA; Mesheryakov AA; Scanlan MJ; Old LJ; Nedospasov SA; Kuprash DV
    Russ J Immunol; 2002 Oct; 7(3):229-38. PubMed ID: 12674932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sperm-associated antigens as targets for cancer immunotherapy: expression pattern and humoral immune response in cancer patients.
    Siliņa K; Zayakin P; Kalniņa Z; Ivanova L; Meistere I; Endzeliņš E; Abols A; Stengrēvics A; Leja M; Ducena K; Kozirovskis V; Linē A
    J Immunother; 2011 Jan; 34(1):28-44. PubMed ID: 21150711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycoprotein A34, a novel target for antibody-based cancer immunotherapy.
    Scanlan MJ; Ritter G; Yin BW; Williams C; Cohen LS; Coplan KA; Fortunato SR; Frosina D; Lee SY; Murray AE; Chua R; Filonenko VV; Sato E; Old LJ; Jungbluth AA
    Cancer Immun; 2006 Jan; 6():2. PubMed ID: 16405301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.